Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of PH-797804 in adults with moderate to severe COPD on a background of tiotropium. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PH-797804

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED